Shanghai Xinzhi Biomed Co., Ltd.

This early-stage study tests the safety of a new gene therapy called BBM-P002 for people with Parkinson's disease. The treatment is injected directly into a specific part of the brain. The study involves 18 participants who have had Parkinson's for at least 5 years. The main goal…

This study tests a one-time gene therapy (BBM-H803) for adults with severe hemophilia A. The treatment uses a harmless virus to deliver a working gene, helping the body produce its own clotting factor. The goal is to reduce or prevent dangerous bleeding episodes. Researchers will…